Infectious Diseases Resource Center

Click on the subcategory below to find drug monographs for that particular area.

Medicinal Mushrooms: Disease Fighters!

A significant number of modern prescription medications have been derived from mushrooms.

Vaccinating Immunodeficient Patients

Immunization with live viral or bacterial vaccines is known to be hazardous for vulnerable patient populations with serious immunodeficiencies.

Worst Measles Outbreak in 20 Years

Public health officials in Orange County, CA are reporting that a measles outbreak is the worst in two decades.

Noxafil New Formulation

Merck announced that the FDA has approved Noxafil injection, a new formulation of the antifungal agent Noxafil for intravenous (IV) use.

Gene Therapy May "Cure" HIV

Genome editing technology has been safely engineered to help provide resistance to HIV infection.

Bovine Colostrum: Multiple Uses?

Bovine colostrum is being studied as a wound-healing agent, an antimicrobial, and an anticancer therapy.

New Drug Product: Sovaldi

As a component of a combination antiviral treatment regimen for chronic hepatitis C (CHC) genotype 1, 2, 3, or 4 infection.

Chart: Community Acquired Pneumonia

Learn more with this clinical reference.

Videos

News

Gilead Releases Data on HCV, Advanced Liver Disease Studies

Gilead Sciences has announced data from a Phase 2 study evaluating once-daily Sovaldi (sofosbuvir) 400mg for the treatment of chronic hepatitis C virus (HCV) infection in patients with advanced liver disease.

As Ebola Outbreak Spreads, Vaccine Efforts Underway

As a major outbreak of Ebola virus spreads through the West African nations of Guinea and Liberia, efforts are underway to develop a vaccine.

Cytomegalovirus Tied to Anemia With CKD

Cytomegalovirus may contribute to anemia in patients with chronic kidney disease.

Two Phase 2 Trials Report Positive Sofosbuvir Data in HCV

Gilead Sciences announced promising efficacy results of sofosbuvir (SOF) in combination with ledipasvir and GS-5816 from two Phase 2 clinical trials on chronic hepatitis C virus (HCV) infection.

Positive Simeprevir Data in Multiple Phase 2 and 3 Studies

Janssen announced positive new data from the simeprevir clinical program, including data from the Phase 2 COSMOS study, the Phase 3 RESTORE, QUEST-1, QUEST-2, and the PROMISE studies.

Featured courses from mycme

Laws and Rules of the Florida Board of NursingExternal web site

This course reviews the purpose and membership of the Florida Board of Nursing (FBON), its ...

CE 2.00 Credits

Domestic Violence 3 Hour: Focus on Child Abuse for Kentucky Health ProfessionalsExternal web site

This course defines domestic violence as family violence, and further differentiates the categories of intimate ...

CE 3.00 Credits

Domestic Violence 3 Hour: Focus on Child Abuse for Florida Health ProfessionalsExternal web site

This course defines domestic violence as family violence, and further differentiates the categories of intimate ...

CE 3.00 Credits
More myCME courses »

Sign Up for Free e-newsletters